# OnCo record mevrometostat (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mevrometostat/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mevrometostat" ;
  schema:name "Mevrometostat"@en ;
  schema:description "An epigenetic drug that may re-sensitise prostate cancer to hormone therapy, in three phase 3 trials with enzalutamide."@en ;
  schema:url <https://onco.cc/drugs/mevrometostat/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://www.tandfonline.com/doi/full/10.1080/14796694.2026.2667441> ;
  onco:status "phase-3" ;
  onco:modality "Small-molecule EZH2 inhibitor" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/> ;
  onco:targets <https://onco.cc/targets/ezh2/>, <https://onco.cc/targets/androgen-receptor/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:trials <https://onco.cc/trials/mevpro-1/>, <https://onco.cc/trials/nct06629779/>, <https://onco.cc/trials/nct07028853/> .